Angiotensin II Receptor Market by Product Type and Application - Global Industry Analysis & Forecast to 2027
Published On : November 2019 Pages : 150 Category: Healthcare IT Report Code : HC116790
Angiotensin II Receptor Market By Product Type (C-21, EMA-401, KDT-501, MOR-107) and Application (Immunology, Women's Health, Respiratory, and Acute Ischemic Stroke) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Angiotensin II Receptor Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Increasing incidence of target diseases such as hypertension, kidney failure from diabetes, across the globe coupled with rising geriatric population is expected to stimulate market growth.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Angiotensin II Receptor Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- CJ HealthCare Corp
- MorphoSys AG
- Novartis AG
- Vicore Pharma AB
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Angiotensin II Receptor Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o C-21
o EMA-401
o KDT-501
o MOR-107
· Angiotensin II Receptor Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Immunology
o Women's Health
o Respiratory
o Acute Ischemic Stroke
· Angiotensin II Receptor Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o CJ HealthCare Corp
o MorphoSys AG
o Novartis AG
o Vicore Pharma AB
· Angiotensin II Receptor Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Angiotensin II Receptor Market, By Country
o U.S. Angiotensin II Receptor Market
o Canada Angiotensin II Receptor Market
o Mexico Angiotensin II Receptor Market
o Europe
§ Europe Angiotensin II Receptor Market, By Country
o Germany Angiotensin II Receptor Market
o UK Angiotensin II Receptor Market
o France Angiotensin II Receptor Market
o Russia Angiotensin II Receptor Market
o Italy Angiotensin II Receptor Market
o Rest of Europe Angiotensin II Receptor Market
o Asia-Pacific
§ Asia-Pacific Angiotensin II Receptor Market, By Country
o China Angiotensin II Receptor Market
o Japan Angiotensin II Receptor Market
o South Korea Angiotensin II Receptor Market
o India Angiotensin II Receptor Market
o Southeast Asia Angiotensin II Receptor Market
o Rest of Asia-Pacific Angiotensin II Receptor Market
o South America
§ South America Angiotensin II Receptor Market
o Brazil Angiotensin II Receptor Market
o Argentina Angiotensin II Receptor Market
o Columbia Angiotensin II Receptor Market
o Rest of South America Angiotensin II Receptor Market
o Middle East and Africa
§ Middle East and Africa Angiotensin II Receptor Market
o Saudi Arabia Angiotensin II Receptor Market
o UAE Angiotensin II Receptor Market
o Egypt Angiotensin II Receptor Market
o Nigeria Angiotensin II Receptor Market
o South Africa Angiotensin II Receptor Market
o Rest of MEA Angiotensin II Receptor Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Angiotensin II Receptor Market, By Product Type
5.1. Introduction
5.2. Global Angiotensin II Receptor Revenue and Market Share by Product Type (2017-2027)
5.2.1. Global Angiotensin II Receptor Revenue and Revenue Share by Product Type (2017-2027)
5.3. C-21
5.3.1. Global C-21 Revenue and Growth Rate (2017-2027)
5.4. EMA-401
5.4.1. Global EMA-401 Revenue and Growth Rate (2017-2027)
5.5. KDT-501
5.5.1. Global KDT-501 Revenue and Growth Rate (2017-2027)
5.6. MOR-107
5.6.1. Global MOR-107 Revenue and Growth Rate (2017-2027)
6. Angiotensin II Receptor Market, By Application
6.1. Introduction
6.2. Global Angiotensin II Receptor Revenue and Market Share by Application (2017-2027)
6.2.1. Global Angiotensin II Receptor Revenue and Revenue Share by Application (2017-2027)
6.3. Immunology
6.3.1. Global Immunology Revenue and Growth Rate (2017-2027)
6.4. Women's Health
6.4.1. Global Women's Health Revenue and Growth Rate (2017-2027)
6.5. Respiratory
6.5.1. Global Respiratory Revenue and Growth Rate (2017-2027)
6.6. Acute Ischemic Stroke
6.6.1. Global Acute Ischemic Stroke Revenue and Growth Rate (2017-2027)
7. Angiotensin II Receptor Market, By Region
7.1. Introduction
7.2. Global Angiotensin II Receptor Revenue and Market Share by Regions
7.2.1. Global Angiotensin II Receptor Revenue by Regions (2017-2027)
7.3. North America Angiotensin II Receptor by Countries
7.3.1. North America Angiotensin II Receptor Revenue and Growth Rate (2017-2027)
7.3.2. North America Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Angiotensin II Receptor by Countries
7.4.1. Europe Angiotensin II Receptor Revenue and Growth Rate (2017-2027)
7.4.2. Europe Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Angiotensin II Receptor by Countries
7.5.1. Asia-Pacific Angiotensin II Receptor Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Angiotensin II Receptor by Countries
7.6.1. South America Angiotensin II Receptor Revenue and Growth Rate (2017-2027)
7.6.2. South America Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Angiotensin II Receptor by Countries
7.7.1. Middle East and Africa Angiotensin II Receptor Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. CJ HealthCare Corp
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. MorphoSys AG
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Novartis AG
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Vicore Pharma AB
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
9. Angiotensin II Receptor Market Forecast (2017-2027)
9.1. Global Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Angiotensin II Receptor Market Forecast by Regions (2017-2027)
9.2.1. North America Angiotensin II Receptor Market Forecast (2017-2027)
9.2.1.1. United States Angiotensin II Receptor Market Forecast (2017-2027)
9.2.1.2. Canada Angiotensin II Receptor Market Forecast (2017-2027)
9.2.1.3. Mexico Angiotensin II Receptor Market Forecast (2017-2027)
9.2.2. Europe Angiotensin II Receptor Market Forecast (2017-2027)
9.2.2.1. Germany Angiotensin II Receptor Market Forecast (2017-2027)
9.2.2.2. France Angiotensin II Receptor Market Forecast (2017-2027)
9.2.2.3. UK Angiotensin II Receptor Market Forecast (2017-2027)
9.2.2.4. Russia Angiotensin II Receptor Market Forecast (2017-2027)
9.2.2.5. Italy Angiotensin II Receptor Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Angiotensin II Receptor Market Forecast (2017-2027)
9.2.3. Asia-Pacific Angiotensin II Receptor Market Forecast (2017-2027)
9.2.3.1. China Angiotensin II Receptor Market Forecast (2017-2027)
9.2.3.2. Japan Angiotensin II Receptor Market Forecast (2017-2027)
9.2.3.3. Korea Angiotensin II Receptor Market Forecast (2017-2027)
9.2.3.4. India Angiotensin II Receptor Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Angiotensin II Receptor Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Angiotensin II Receptor Market Forecast (2017-2027)
9.2.4. South America Angiotensin II Receptor Market Forecast (2017-2027)
9.2.4.1. Brazil Angiotensin II Receptor Market Forecast (2017-2027)
9.2.4.2. Argentina Angiotensin II Receptor Market Forecast (2017-2027)
9.2.4.3. Columbia Angiotensin II Receptor Market Forecast (2017-2027)
9.2.4.4. Rest of South America Angiotensin II Receptor Market Forecast (2017-2027)
9.2.5. Middle East and Africa Angiotensin II Receptor Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Angiotensin II Receptor Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Angiotensin II Receptor Market Forecast (2017-2027)
9.2.5.3. Egypt Angiotensin II Receptor Market Forecast (2017-2027)
9.2.5.4. Nigeria Angiotensin II Receptor Market Forecast (2017-2027)
9.2.5.5. South Africa Angiotensin II Receptor Market Forecast (2017-2027)
9.2.5.6. Turkey Angiotensin II Receptor Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Angiotensin II Receptor Market Forecast (2017-2027)
9.3. Angiotensin II Receptor Market Forecast by Product Type (2017-2027)
9.3.1. Angiotensin II Receptor Forecast by Product Type (2017-2027)
9.3.2. Angiotensin II Receptor Market Share Forecast by Product Type (2017-2027)
9.4. Angiotensin II Receptor Market Forecast by Application (2017-2027)
9.4.1. Angiotensin II Receptor Forecast by Application (2017-2027)
9.4.2. Angiotensin II Receptor Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Angiotensin II Receptor Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Angiotensin II Receptor Revenue and Revenue Share by Product Type (2017-2018)
Figure Global C-21 Revenue and Growth Rate (2017-2018)
Figure Global EMA-401 Revenue and Growth Rate (2017-2018)
Figure Global KDT-501 Revenue and Growth Rate (2017-2018)
Figure Global MOR-107 Revenue and Growth Rate (2017-2018)
Table Global Angiotensin II Receptor Revenue and Revenue Share by Application (2017-2018)
Figure Global Immunology Revenue and Growth Rate (2017-2018)
Figure Global Women's Health Revenue and Growth Rate (2017-2018)
Figure Global Respiratory Revenue and Growth Rate (2017-2018)
Figure Global Acute Ischemic Stroke Revenue and Growth Rate (2017-2018)
Table Global Angiotensin II Receptor Revenue by Regions (2017-2018)
Figure North America Angiotensin II Receptor Growth Rate (2017-2018)
Figure North America Angiotensin II Receptor Revenue and Growth Rate (2017-2018)
Figure North America Angiotensin II Receptor by Countries (2017-2018)
Figure North America Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2018)
Figure United States Angiotensin II Receptor Growth Rate (2017-2018)
Figure United States Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Angiotensin II Receptor Growth Rate (2017-2018)
Figure Canada Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Angiotensin II Receptor Growth Rate (2017-2018)
Figure Mexico Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Angiotensin II Receptor Growth Rate (2017-2018)
Figure Europe Angiotensin II Receptor Revenue and Growth Rate (2017-2018)
Figure Europe Angiotensin II Receptor by Countries (2017-2018)
Figure Europe Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2018)
Figure Germany Angiotensin II Receptor Growth Rate (2017-2018)
Figure Germany Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Angiotensin II Receptor Growth Rate (2017-2018)
Figure France Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Angiotensin II Receptor Growth Rate (2017-2018)
Figure UK Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Angiotensin II Receptor Growth Rate (2017-2018)
Figure Russia Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Angiotensin II Receptor Growth Rate (2017-2018)
Figure Italy Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Angiotensin II Receptor Growth Rate (2017-2018)
Figure Rest of Europe Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Angiotensin II Receptor Growth Rate (2017-2018)
Figure Asia-Pacific Angiotensin II Receptor Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Angiotensin II Receptor by Countries (2017-2018)
Figure Asia-Pacific Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2018)
Figure China Angiotensin II Receptor Growth Rate (2017-2018)
Figure China Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Angiotensin II Receptor Growth Rate (2017-2018)
Figure Japan Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Angiotensin II Receptor Growth Rate (2017-2018)
Figure Korea Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Angiotensin II Receptor Growth Rate (2017-2018)
Figure India Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Angiotensin II Receptor Growth Rate (2017-2018)
Figure Southeast Asia Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Angiotensin II Receptor Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Angiotensin II Receptor Growth Rate (2017-2018)
Figure South America Angiotensin II Receptor Revenue and Growth Rate (2017-2018)
Figure South America Angiotensin II Receptor by Countries (2017-2018)
Figure South America Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Angiotensin II Receptor Growth Rate (2017-2018)
Figure Brazil Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Angiotensin II Receptor Growth Rate (2017-2018)
Figure Argentina Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Angiotensin II Receptor Growth Rate (2017-2018)
Figure Columbia Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Angiotensin II Receptor Growth Rate (2017-2018)
Figure Rest of South America Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Angiotensin II Receptor Growth Rate (2017-2018)
Figure Middle East and Africa Angiotensin II Receptor Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Angiotensin II Receptor by Countries (2017-2018)
Figure Middle East and Africa Angiotensin II Receptor Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Angiotensin II Receptor Growth Rate (2017-2018)
Figure Saudi Arabia Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Angiotensin II Receptor Growth Rate (2017-2018)
Figure United Arab Emirates Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Angiotensin II Receptor Growth Rate (2017-2018)
Figure Egypt Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Angiotensin II Receptor Growth Rate (2017-2018)
Figure Nigeria Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Angiotensin II Receptor Growth Rate (2017-2018)
Figure South Africa Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Angiotensin II Receptor Growth Rate (2017-2018)
Figure Turkey Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Angiotensin II Receptor Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2017-2018)
Table CJ HealthCare Corp Angiotensin II Receptor Financial Overview
Table MorphoSys AG Angiotensin II Receptor Financial Overview
Table Novartis AG Angiotensin II Receptor Financial Overview
Table Vicore Pharma AB Angiotensin II Receptor Financial Overview
Figure Global Angiotensin II Receptor Revenue (Millions USD) and Growth Rate (2018-2025)
Table Angiotensin II Receptor Market Forecast by Regions (2018-2025)
Figure North America Angiotensin II Receptor Market Forecast (2018-2025)
Figure United States Angiotensin II Receptor Market Forecast (2018-2025)
Figure Canada Angiotensin II Receptor Market Forecast (2018-2025)
Figure Mexico Angiotensin II Receptor Market Forecast (2018-2025)
Figure Europe Angiotensin II Receptor Market Forecast (2018-2025)
Figure Germany Angiotensin II Receptor Market Forecast (2018-2025)
Figure France Angiotensin II Receptor Market Forecast (2018-2025)
Figure UK Angiotensin II Receptor Market Forecast (2018-2025)
Figure Russia Angiotensin II Receptor Market Forecast (2018-2025)
Figure Italy Angiotensin II Receptor Market Forecast (2018-2025)
Figure Rest of Europe Angiotensin II Receptor Market Forecast (2018-2025)
Figure Asia-Pacific Angiotensin II Receptor Market Forecast (2018-2025)
Figure China Angiotensin II Receptor Market Forecast (2018-2025)
Figure Japan Angiotensin II Receptor Market Forecast (2018-2025)
Figure Korea Angiotensin II Receptor Market Forecast (2018-2025)
Figure India Angiotensin II Receptor Market Forecast (2018-2025)
Figure Southeast Asia Angiotensin II Receptor Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Angiotensin II Receptor Market Forecast (2018-2025)
Figure South America Angiotensin II Receptor Market Forecast (2018-2025)
Figure Brazil Angiotensin II Receptor Market Forecast (2018-2025)
Figure Argentina Angiotensin II Receptor Market Forecast (2018-2025)
Figure Columbia Angiotensin II Receptor Market Forecast (2018-2025)
Figure Rest of South America Angiotensin II Receptor Market Forecast (2018-2025)
Figure Middle East and Africa Angiotensin II Receptor Market Forecast (2018-2025)
Figure Saudi Arabia Angiotensin II Receptor Market Forecast (2018-2025)
Figure United Arab Emirates Angiotensin II Receptor Market Forecast (2018-2025)
Figure Egypt Angiotensin II Receptor Market Forecast (2018-2025)
Figure Nigeria Angiotensin II Receptor Market Forecast (2018-2025)
Figure South Africa Angiotensin II Receptor Market Forecast (2018-2025)
Figure Turkey Angiotensin II Receptor Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Angiotensin II Receptor Market Forecast (2018-2025)
Figure Global Angiotensin II Receptor Forecast by Product Type (2018-2025)
Figure Global Angiotensin II Receptor Market Share Forecast by Product Type (2018-2025)
Figure Global Angiotensin II Receptor Forecast by Product Type (2018-2025)
Figure Global Angiotensin II Receptor Forecast by Application (2018-2025)
Figure Global Angiotensin II Receptor Market Share Forecast by Application (2018-2025)
Figure Global Angiotensin II Receptor Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|